Antengene Announces Latest Clinical Trial Data of ATG-008 (onatasertib) to be presented in the upcoming 2022 American Society of Clinical Oncology Annual Meeting ...Middle East

SHANGHAI and HONG KONG, April 29, 2022 /PRNewswire/ -- Antengene Corporation Limited ("Antengene" SEHK: 6996.HK), a leading innovative, global biopharmaceutical company dedicated to discovering, developing and commercializing first-in-class and/or best-in-class therapeutics in hematology...

Read More Details
Finally We wish PressBee provided you with enough information of ( Antengene Announces Latest Clinical Trial Data of ATG-008 (onatasertib) to be presented in the upcoming 2022 American Society of Clinical Oncology Annual Meeting )

Also on site :

• Ukraine doing West’s ‘dirty work’ in Africa – Sudanese official
• Two people killed by falling trees and thousands without power after storms sweep southern states
• 'He knows where to find me,' Newsom responds to Trump administration arrest threat